Females Adapt to Dietary Protein Restriction on Enhanced Gut-Brain Axis during Aging

Vaddi, P.; Godoy-Lugo, J. A.; Young, K. E.; Batamack, Y.; Donkor, M.; Artison, A.; Christensen, A.; Pike, C. J.; Hill, C.

doi:10.64898/2026.06.29.735363

Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.06.29.735363

Females Adapt to Dietary Protein Restriction on Enhanced Gut-Brain Axis during Aging

Vaddi, P.·Godoy-Lugo, J. A.·Young, K. E.·Batamack, Y.·Donkor, M.·Artison, A.·Christensen, A.·Pike, C. J.·Hill, C.

View original source ↗Export metadata ↓

Abstract

Growing evidence supports a critical role for the gut-brain axis in regulating metabolic health, inflammation, and cognitive function during aging. Age-associated gut dysbiosis has been linked to metabolic dysfunction and cognitive decline, with females exhibiting increased susceptibility to these age-related impairments. Diet is a major determinant of gut microbiome composition and function. Previous studies from our laboratory demonstrated that dietary protein restriction (DPR) induces fibroblast growth factor 21 (FGF21), improves metabolic health, and extends lifespan in male mice. However, the effects of DPR on the gut microbiome and associated health outcomes in aged female mice remain poorly understood. Female mice were assigned at 16 months of age to either a normal-protein (NP) or low-protein (LP) diet for 26 weeks. Metabolic assessments included food intake, fasting glucose concentrations, and glucose tolerance testing. Senescence-associated markers in mesenteric white adipose tissue (mWAT), fecal microbiome composition, and behavioral outcomes were evaluated to determine relationships among dietary protein intake, microbial communities, metabolic health, and cognitive function. Low-protein diet significantly improved metabolic health in aged female mice, as evidenced by improved glucose regulation. Microbiome analyses revealed increased abundance of Akkermansia at 17 months and Faecalibaculum in LP-fed animals at 22 months of age. More so, functional profiling and gene set enrichment analyses indicated enrichment of microbial pathways associated with membrane integrity and metal ion binding. Lastly, LP-fed female mice displayed improved memory performance at 22 months of age compared with age-matched NP-fed controls. Collectively, these findings demonstrate that DPR remodels the gut microbiome and improves metabolic and cognitive health in aged female mice. The observed microbial adaptations may contribute to the beneficial effects of DPR on aging-related physiology, highlighting the gut microbiome as a potential mediator of dietary interventions that promote healthy aging.

Explore related subjects

physiology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Vaddi, P., Godoy-Lugo, J. A., Young, K. E., Batamack, Y., Donkor, M., Artison, A., Christensen, A., Pike, C. J., Hill, C.. 2026-07-03. Females Adapt to Dietary Protein Restriction on Enhanced Gut-Brain Axis during Aging. https://doi.org/10.64898/2026.06.29.735363

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

28S-rsRNA facilitates PASMC proliferation through PKM2 β-hydroxybutyrylation

Ribosomal RNA-derived small RNAs (rsRNAs) are nucleic acid fragments originating from rRNA, the functions and roles of which in diseases remain incompletely understood. We identified 28S rsRNA-CTC_L20, an rsRNA whose expression is upregulated in hypoxic pulmonary artery smooth muscle cells (PASMCs) and in lung tissues of pulmonary hypertension (PH) models. In hypoxic cells, 28S rsRNA-CTC_L20 promotes PASMC proliferation, and its knockdown mitigates SuHx-induced pulmonary hypertension and vascular remodeling. Mechanistically, 28S rsRNA-CTC_L20 modulates {beta}-hydroxybutyrate (BHB) production by maintaining the stability of ketogenic enzyme mRNAs through its "CTGNNGG" motif. Elevated levels of BHB enhance the {beta}-hydroxybutyrylation modification at K166 of pyruvate kinase M2 (PKM2), increasing its activity and driving glycolysis to sustain proliferation. These results link ketone body metabolism to glycolysis in hypoxic cells and define an rsRNA-BHB-PKM2 {beta}-hydroxybutyrylation axis in PH. They also point to 28S rsRNA-CTC_L20 as a potential target for treating vascular remodeling.

physiology↗

bioRxiv2026

Selective activation of estrogen receptors modulates electrical activity and insulin secretion in human EndoC-βH1 cells

Estrogen receptors (ERs), ER and ER{beta} have important roles in the physiology of the endocrine pancreas in animal models, but the effects of ER activation on insulin-secreting human cells are still poorly understood. Here, we investigated the role of ER and ER{beta} as modulators of electrical activity and insulin secretion in the insulin-secreting human cell line EndoC-{beta}H1. Immunocytochemical analysis revealed a widespread cellular distribution of ER, while ER{beta} was predominantly localized outside the nucleus. We observed that both estradiol (E2) and the ER{beta} agonist diarylpropionitrile (DPN) led to a decrease in insulin secretion in the absence of stimulatory glucose concentrations, without affecting insulin content. Patch-clamp experiments revealed that a 48-hour treatment with either the ER agonist PPT or DPN resulted in depolarization of the resting membrane potential, increased action potential firing frequency, and altered the action potential waveform in EndoC-{beta}H1 cells. PPT increased voltage-dependent Ca2+ channel currents, while DPN reduced K+ and Na+ currents. These results suggest that activation of ER and ER{beta} modulates beta-cell electrical activity through distinct pathways involving ion channels. The effects of E2, PPT, and DPN were not caused by altered expression levels of ion channel genes after 48 hours of treatment. This suggests that these receptors act extranuclearly without affecting gene expression. Together, our findings demonstrate that selective activation of ER and ER{beta} modulates beta-cell excitability through distinct electrophysiological mechanisms and that E2 and DPN reduce basal insulin secretion in human EndoC-{beta}H1 cells. These results support ER and ER{beta} as potential targets for modulating human pancreatic beta-cell function.

physiology↗

bioRxiv2026

Body weight modifies the efficacy of lifespan-extending interventions in ad libitum-fed mice

Geroprotective interventions are often assessed by extension of lifespan in ad libitum-fed mice. Increased lifespan could therefore reflect rescue of adverse phenotypes of unhealthy controls. We analysed body weight and survival for 33,780 mice in the Interventions Testing Program (ITP) to test whether treatment effects varied with body weight. In males, each added standard deviation of attained adult weight made treatment 6% more favourable (HR 0.94), more apparent for interventions that lowered body weight (HR 0.90). Median lifespan increase rose from 6.2% in mice in the lightest quartile to 20.2% in the heaviest pre-dosing weight quartile among those experiments, mainly because control survival declined more steeply with weight than that of the intervention group. The effect of body weight was consistent across 13 of 14 compounds and reflected weight attained during adulthood rather than in early life. Weight-dependence of intervention effects was weak in ITP females, possibly because median survival of controls exceeded that of every sampled non-ITP female control group. Amelioration of weight-associated risk is therefore implicated as a major contributor to lifespan increases relative to heavy, short-lived controls. The geroprotective effects of these interventions may thus be less apparent in metabolically healthier mice or humans.

physiology↗